| Prospective comparison of 18F-fluoromethylcholine versus 68Ga-PSMA PET/CT in prostate cancer patients who have rising PSA after curative treatment and are being considered for … JJ Morigi, PD Stricker, PJ van Leeuwen, R Tang, B Ho, Q Nguyen, ... Journal of nuclear medicine 56 (8), 1185-1190, 2015 | 660 | 2015 |
| Prospective evaluation of 68Gallium‐prostate‐specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer PJ van Leeuwen, L Emmett, B Ho, W Delprado, F Ting, Q Nguyen, ... BJU international 119 (2), 209-215, 2017 | 333 | 2017 |
| 68Ga‐PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment PJ van Leeuwen, P Stricker, G Hruby, A Kneebone, F Ting, B Thompson, ... BJU international 117 (5), 732-739, 2016 | 321 | 2016 |
| A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial T Wolters, MJ Roobol, PJ van Leeuwen, RCN van den Bergh, ... The Journal of urology 185 (1), 121-125, 2011 | 304 | 2011 |
| Performance of the prostate cancer antigen 3 (PCA3) gene and prostate-specific antigen in prescreened men: exploring the value of PCA3 for a first-line diagnostic test MJ Roobol, FH Schröder, P van Leeuwen, T Wolters, RCN van den Bergh, ... European urology 58 (4), 475-481, 2010 | 220 | 2010 |
| Treatment outcomes from 68Ga-PSMA PET/CT–informed salvage radiation treatment in men with rising PSA after radical prostatectomy: prognostic value of a negative PSMA PET L Emmett, PJ van Leeuwen, R Nandurkar, MJ Scheltema, T Cusick, ... Journal of Nuclear Medicine 58 (12), 1972-1976, 2017 | 195 | 2017 |
| The diagnostic performance of multiparametric magnetic resonance imaging to detect significant prostate cancer JE Thompson, PJ Van Leeuwen, D Moses, R Shnier, P Brenner, ... The Journal of urology 195 (5), 1428-1435, 2016 | 194 | 2016 |
| A multiparametric magnetic resonance imaging‐based risk model to determine the risk of significant prostate cancer prior to biopsy PJ van Leeuwen, A Hayen, JE Thompson, D Moses, R Shnier, M Böhm, ... BJU international 120 (6), 774-781, 2017 | 136 | 2017 |
| Focal irreversible electroporation for prostate cancer: functional outcomes and short-term oncological control F Ting, M Tran, M Böhm, A Siriwardana, PJ Van Leeuwen, AM Haynes, ... Prostate cancer and prostatic diseases 19 (1), 46-52, 2016 | 123 | 2016 |
| Artificial intelligence and robotics: a combination that is changing the operating room I Andras, E Mazzone, FWB van Leeuwen, G De Naeyer, ... World journal of urology 38, 2359-2366, 2020 | 122 | 2020 |
| 3-Year freedom from progression after 68Ga-PSMA PET/CT–triaged management in men with biochemical recurrence after radical prostatectomy: results of a prospective multicenter trial L Emmett, R Tang, R Nandurkar, G Hruby, P Roach, JA Watts, T Cusick, ... Journal of Nuclear Medicine 61 (6), 866-872, 2020 | 119 | 2020 |
| Is delayed radical prostatectomy in men with low‐risk screen‐detected prostate cancer associated with a higher risk of unfavorable outcomes? RCN van den Bergh, EW Steyerberg, A Khatami, G Aus, CG Pihl, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2010 | 118 | 2010 |
| Diagnostic accuracy of 68Ga‐prostate‐specific membrane antigen (PSMA) positron‐emission tomography (PET) and multiparametric (mp)MRI to detect intermediate‐grade … MJ Scheltema, JI Chang, PD Stricker, PJ van Leeuwen, QA Nguyen, B Ho, ... BJU international 124, 42-49, 2019 | 115 | 2019 |
| Use of gallium‐68 prostate‐specific membrane antigen positron‐emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of … HB Luiting, PJ van Leeuwen, MB Busstra, T Brabander, HG van der Poel, ... BJU international 125 (2), 206-214, 2020 | 106 | 2020 |
| Prostate cancer mortality in screen and clinically detected prostate cancer: estimating the screening benefit PJ Van Leeuwen, D Connolly, A Gavin, MJ Roobol, A Black, CH Bangma, ... European Journal of Cancer 46 (2), 377-383, 2010 | 92 | 2010 |
| Should pathologists routinely report prostate tumour volume? The prognostic value of tumour volume in prostate cancer T Wolters, MJ Roobol, PJ van Leeuwen, RCN van den Bergh, ... European urology 57 (5), 821-829, 2010 | 90 | 2010 |
| A DROP-IN gamma probe for robot-assisted radioguided surgery of lymph nodes during radical prostatectomy P Dell’Oglio, P Meershoek, T Maurer, EMK Wit, PJ van Leeuwen, ... European Urology 79 (1), 124-132, 2021 | 81 | 2021 |
| Robot-assisted laparoscopic surgery using DROP-IN radioguidance: first-in-human translation P Meershoek, MN van Oosterom, H Simon, L Mengus, T Maurer, ... European journal of nuclear medicine and molecular imaging 46, 49-53, 2019 | 81 | 2019 |
| Initial multicentre experience of 68gallium‐PSMA PET/CT guided robot‐assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit … A Siriwardana, J Thompson, PJ van Leeuwen, S Doig, A Kalsbeek, ... BJU international 120 (5), 673-681, 2017 | 73 | 2017 |
| Eleven-year outcome of patients with prostate cancers diagnosed during screening after initial negative sextant biopsies FH Schröder, RCN van den Bergh, T Wolters, PJ van Leeuwen, ... European urology 57 (2), 256-266, 2010 | 68 | 2010 |
